Market by Technology, Diagnostic Method, Product, Pathogen, Testing Type, and Country | Forecast 2021-2028
As stated in Triton’s research
report, the sepsis diagnostics market in the Middle East and Africa is
estimated to witness growth at a CAGR of 7.00% over the projected phase
2021-2028.
Report scope can be customized per your requirements. Request For Customization
The countries considered for
analysis in this market are:
• The United Arab Emirates
• Turkey
• South Africa
• Saudi Arabia
• Rest of Middle East & Africa
In Saudi Arabia, a significant
number of patients admitted to the hospital had sepsis, with many patients
dying due to sepsis shock. Moreover, as per a study using the neonatal
intensive care unit database in King Fahad Medical City, neonatal sepsis’s mortality
rate is higher in early-onset than late-onset. In addition, sepsis can turn out
to be fatal as it can cause several abnormalities in the body, leading to
death. Hence, the factors mentioned above are likely to increase the demand for
sepsis diagnostics to prevent premature deaths, thereby supplementing the
growth of the sepsis diagnostics market within the country.
Additionally, as per experts,
sepsis coupled with COVID-19 can lead to severe conditions, including organ
failure. In the United Arab Emirates, sepsis occurs among high-risk groups,
such as people with a low immunity level. Considering the medical condition,
the severity of sepsis varies. The government’s strong advocacy for diagnosis
sepsis and implementing necessary treatment programs using evidence-based
medicine is one of the major factors contributing to the nation’s high rank in
responding to COVID-19. Furthermore, the demand for diagnostic tests is likely
to increase to prevent the disease’s burden, which is estimated to support the
growth of the sepsis diagnostics market over the registered period in the UAE.
Becton Dickinson and Company is a global company engaged in developing, manufacturing, and marketing medical devices, laboratory equipment, and diagnostic products. Its major products include respiratory ventilation, diagnostics equipment, instruments to detect infectious diseases, clinical research tools, infusion pumps and disposables, automated medication dispensing systems, and others. The company provides its products to life science researchers, healthcare institutions, and clinical laboratories, among others. It has set its operations across multiple regions, such as the Middle East and Africa.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. MIDDLE
EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON SEPSIS DIAGNOSTICS MARKET
2.2. KEY
INSIGHTS
2.3. PORTER’S
FIVE FORCES MODEL
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. COMPETITIVE
RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. CONTRACTS
AND PARTNERSHIP
2.6.2. BUSINESS
EXPANSION AND DIVESTITURES
2.6.3. ACQUISITIONS
& MERGERS
2.6.4. NEW
PRODUCT LAUNCHES
2.7. MARKET
DRIVERS
2.7.1. RISE
IN HOSPITAL-ACQUIRED INFECTIONS AMONG PATIENTS
2.7.2. INCREASED
PREVALENCE OF SEPSIS
2.8. MARKET
RESTRAINTS
2.8.1. HIGH
COST ASSOCIATED WITH THE INSTRUMENT
2.8.2. REIMBURSEMENT
ISSUES
2.9. MARKET
OPPORTUNITIES
2.9.1. GROWTH
OPPORTUNITIES IN THE EMERGING ECONOMIES
3. MIDDLE
EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET - BY TECHNOLOGY
3.1. MICROBIOLOGY
3.2. IMMUNOASSAY
3.3. MOLECULAR
DIAGNOSTICS
3.4. OTHER
TECHNOLOGIES
4. MIDDLE
EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET - BY DIAGNOSTIC METHOD
4.1. CONVENTIONAL
DIAGNOSTICS
4.2. AUTOMATED
DIAGNOSTICS
5. MIDDLE
EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET - BY PRODUCT
5.1. BLOOD
CULTURE MEDIA
5.2. ASSAY
KITS & REAGENTS
5.3. INSTRUMENTS
6. MIDDLE
EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET - BY PATHOGEN
6.1. GRAM
- POSITIVE AND GRAM - NEGATIVE BACTERIAL SEPSIS
6.2. FUNGAL
SEPSIS
6.3. OTHER
PATHOGENS
7. MIDDLE
EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET - BY TESTING TYPE
7.1. LABORATORY
TESTING
7.2. POINT-OF-CARE
TESTING
8. MIDDLE
EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET – COUNTRY OUTLOOK
8.1. COUNTRY
ANALYSIS
8.1.1. SAUDI
ARABIA
8.1.2. UNITED
ARAB EMIRATES
8.1.3. TURKEY
8.1.4. SOUTH
AFRICA
8.1.5. REST
OF MIDDLE EAST & AFRICA
9. COMPETITIVE
LANDSCAPE
9.1. ABBOTT
LABORATORIES
9.2. BECTON
DICKINSON AND COMPANY (CR BARD)
9.3. BIOMERIEUX
SA
9.4. BRUKER
CORPORATION
9.5. CYTOSORBENTS
9.6. DANAHER
CORPORATION
9.7. EKF
DIAGNOSTICS
9.8. F
HOFFMANN-LA ROCHE
9.9. IMMUNEXPRESS
INC
9.10. LUMINEX
CORPORATION
9.11. RESPONSE
BIOMEDICAL CORPORATION
9.12. T2
BIOSYSTEMS INC
9.13. THERMO
FISHER SCIENTIFIC INC
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH
SCOPE & DELIVERABLES
10.1.1. OBJECTIVES
OF STUDY
10.1.2. SCOPE
OF STUDY
10.2. SOURCES
OF DATA
10.2.1. PRIMARY
DATA SOURCES
10.2.2. SECONDARY
DATA SOURCES
10.3. RESEARCH
METHODOLOGY
10.3.1. EVALUATION
OF PROPOSED MARKET
10.3.2. IDENTIFICATION
OF DATA SOURCES
10.3.3. ASSESSMENT
OF MARKET DETERMINANTS
10.3.4. DATA
COLLECTION
10.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS
MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: MARKET ATTRACTIVENESS INDEX
TABLE 3: VENDOR SCORECARD
TABLE 4: LIST OF CONTRACTS & PARTNERSHIPS
TABLE 5: LIST OF BUSINESS EXPANSIONS &
DIVESTITURES
TABLE 6: LIST OF ACQUISITIONS & MERGERS
TABLE 7: LIST OF NEW PRODUCT LAUNCHES
TABLE 8: MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS
MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 9: MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS
MARKET, BY DIAGNOSTIC METHOD, 2021-2028 (IN $ MILLION)
TABLE 10: MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS
MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 11: MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS
MARKET, BY PATHOGEN, 2021-2028 (IN $ MILLION)
TABLE 12: GRAM-NEGATIVE BACTERIA CAUSING SEPSIS
TABLE 13: GRAM-POSITIVE BACTERIA CAUSING SEPSIS
TABLE 14: MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS
MARKET, BY TESTING TYPE, 2021-2028 (IN $ MILLION)
TABLE 15: MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS
MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
FIGURE 1: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)
FIGURE 3: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY MICROBIOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 4: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY IMMUNOASSAY, 2021-2028 (IN $ MILLION)
FIGURE 5: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 6: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)
FIGURE 7: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, 2020 & 2028 (IN %)
FIGURE 8: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY CONVENTIONAL DIAGNOSTICS, 2021-2028 (IN $
MILLION)
FIGURE 9: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY AUTOMATED DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 10: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2020 & 2028 (IN %)
FIGURE 11: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY BLOOD CULTURE MEDIA, 2021-2028 (IN $ MILLION)
FIGURE 12: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY ASSAY KITS & REAGENTS, 2021-2028 (IN $
MILLION)
FIGURE 13: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY INSTRUMENTS, 2021-2028 (IN $ MILLION)
FIGURE 14: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2020 & 2028 (IN %)
FIGURE 15: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY GRAM - POSITIVE AND GRAM - NEGATIVE BACTERIAL
SEPSIS, 2021-2028 (IN $ MILLION)
FIGURE 16: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY FUNGAL SEPSIS, 2021-2028 (IN $ MILLION)
FIGURE 17: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY OTHER PATHOGENS, 2021-2028 (IN $ MILLION)
FIGURE 18: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY TESTING TYPE, 2020 & 2028 (IN %)
FIGURE 19: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY LABORATORY TESTING, 2021-2028 (IN $ MILLION)
FIGURE 20: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY POINT-OF-CARE TESTING, 2021-2028 (IN $ MILLION)
FIGURE 21: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 22: SAUDI ARABIA SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: UNITED ARAB EMIRATES
SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 24: TURKEY SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 25: SOUTH AFRICA SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 26: REST OF MIDDLE EAST &
AFRICA SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)
FIGURE 3: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY MICROBIOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 4: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY IMMUNOASSAY, 2021-2028 (IN $ MILLION)
FIGURE 5: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 6: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)
FIGURE 7: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, 2020 & 2028 (IN %)
FIGURE 8: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY CONVENTIONAL DIAGNOSTICS, 2021-2028 (IN $
MILLION)
FIGURE 9: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY AUTOMATED DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 10: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2020 & 2028 (IN %)
FIGURE 11: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY BLOOD CULTURE MEDIA, 2021-2028 (IN $ MILLION)
FIGURE 12: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY ASSAY KITS & REAGENTS, 2021-2028 (IN $
MILLION)
FIGURE 13: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY INSTRUMENTS, 2021-2028 (IN $ MILLION)
FIGURE 14: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2020 & 2028 (IN %)
FIGURE 15: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY GRAM - POSITIVE AND GRAM - NEGATIVE BACTERIAL
SEPSIS, 2021-2028 (IN $ MILLION)
FIGURE 16: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY FUNGAL SEPSIS, 2021-2028 (IN $ MILLION)
FIGURE 17: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY OTHER PATHOGENS, 2021-2028 (IN $ MILLION)
FIGURE 18: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY TESTING TYPE, 2020 & 2028 (IN %)
FIGURE 19: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY LABORATORY TESTING, 2021-2028 (IN $ MILLION)
FIGURE 20: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, BY POINT-OF-CARE TESTING, 2021-2028 (IN $ MILLION)
FIGURE 21: MIDDLE EAST AND AFRICA
SEPSIS DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 22: SAUDI ARABIA SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: UNITED ARAB EMIRATES
SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 24: TURKEY SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 25: SOUTH AFRICA SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 26: REST OF MIDDLE EAST &
AFRICA SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)